Viewing Study NCT04246359


Ignite Creation Date: 2025-12-24 @ 2:32 PM
Ignite Modification Date: 2026-01-06 @ 11:55 AM
Study NCT ID: NCT04246359
Status: UNKNOWN
Last Update Posted: 2022-04-07
First Post: 2020-01-14
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Rituximab and Pegylated Interferon α-2b in Patients With Indolent B-cell Lymphoma
Sponsor: Huiqiang Huang
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module